AstraZeneca, the pharmaceutical giant behind the widely used COVID-19 vaccine Covishield, developed in collaboration with Oxford University, has for the first time acknowledged a rare side effect associated with the vaccine in court documents. The company admitted that Covishield could lead to Continue Reading
The Serum Institute of India (SII) and Bharat Biotech slashed the prices of Covishield and Covaxin vaccines for private hospitals to Rs 225 per dose on Saturday, a day before the Centre rolls out precautionary doses of Covid-19 vaccines to all adults. In private hospitals, each dose of Covishield costs Rs 600, while Covaxin costs […]Continue Reading
According to a study conducted by the National Institute of Virology (NIV) in Pune, neutralising antibody levels in those who were fully vaccinated against the coronavirus with Covishield, Covaxin, or a combination of both — Covishield as the first dose and Covaxin as the second dose – waned after six months in those who were […]Continue Reading
Mia Amor Mottley, Prime Minister of Barbados thanked Narendra Modi via a letter for receiving 100,000 doses of Oxford-AstraZeneca anti-coronavirus vaccine. On February 4, Mottley in the letter said: “On behalf of my government and people, I wish you to express gratitude to you, your government and the people of the Republic of India for […]Continue Reading